Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and ...

New research finds reduced ELOVL2 enzyme activity speeds up immune cell aging and disrupts genes linked to cancer.

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

New research zeroes in on a unique group of immune cells that could transform how we treat—and possibly prevent—severe food ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors — drugs that take the brakes off ...

To assess the applicability of the mouse studies to the human immune system, the researchers analyzed ... The CD79B gene and other B cell-related genes affected by ELOVL2 enzymatic activity ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...